Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Kineta Inc (KA)

Kineta Inc (KA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5746 -0.2544 (-30.69%) 09/18/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.5746 unch (unch) -
News & Headlines for Wed, Sep 18th, 2024
Kineta Announces Completion of Enrollment in the Monotherapy Arm of the VISTA-101 Phase 1 Clinical Study in Advanced Solid Tumors

KA : 0.5746 (-30.69%)
KANT : 0.2750 (-0.36%)
Kineta Announces KVA12123 Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024

KA : 0.5746 (-30.69%)
KANT : 0.2750 (-0.36%)
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board

/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Board of Directors has...

KA : 0.5746 (-30.69%)
XFOR : 0.1953 (-6.11%)
PHAR : 8.09 (-0.86%)
APRE : 1.5371 (-2.72%)

Barchart Exclusives

Analysts Love These 2 Stocks to Buy for Q2
Investors could snag these two stocks as BofA flags the companies as well-positioned winners in an uncertain quarter. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro